Showing results (361-370 of 508) with videos related to

Sort By:
Pageof 51
Journal of Neurology|January 13, 2000
A hypofibrinolytic state in overweight patients with cerebral venous thrombosis and isolated intracranial hypertensionA Quattrone, A Gambardella, A M Carbone, et al.
European Urology Oncology|August 13, 2019
Efficacy of Novel Bromodomain and Extraterminal Inhibitors in Combination with Chemotherapy for Castration-Resistant Prostate CancerRamiro Vázquez, Gianluca Civenni, Aleksandra Kokanovic, et al.
Genes|October 28, 2023
Detection of Cancer-Associated Gene Mutations in Urinary Cell-Free DNA among Prostate Cancer Patients in South AfricaDada Oluwaseyi Temilola, Martha Wium, Juliano Paccez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2020
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)M Montopoli, S Zumerle, R Vettor, et al.
JAMA|September 18, 1996
Career development for women in academic medicine: Multiple interventions in a department of medicineL P Fried, C A Francomano, S M MacDonald, et al.
Cancers|October 17, 2020
Erratum: Mapelli, S.N., et al. A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors). Cancers 2020, 12, 176Sarah N Mapelli, Domenico Albino, Maurizia Mello-Grand, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2017
Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cellsDavide Genini, Lara Brambilla, Erik Laurini, et al.
Cancers|January 16, 2020
A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors)Sarah N Mapelli, Domenico Albino, Maurizia Mello-Grand, et al.
Oncogene|June 27, 2012
Aberrant expression of the neuronal-specific protein DCDC2 promotes malignant phenotypes and is associated with prostate cancer progressionN Longoni, P Kunderfranco, S Pellini, et al.
Cancer Research|May 20, 2016
Activation of the Lin28/let-7 Axis by Loss of ESE3/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate CancerDomenico Albino, Gianluca Civenni, Cecilia Dallavalle, et al.
Pageof 51